Skip to main content

Advertisement

Table 2 Primary outcome measures for the treatment groups after 12 months

From: Surgery is more cost-effective than splinting for carpal tunnel syndrome in the Netherlands: results of an economic evaluation alongside a randomized controlled trial

Primary outcome measures Surgery (n = 73) Splint (n = 83) Difference*
Success rate (%)** 92% (67/73) 72% (60/83) 20% (8; 31)
# nights waking up due to complaints (0–7)** 3.6 (2.9) 2.9 (3.0) 0.7 (-0.2; 1.7)
Severity of the main complaint (0–10)** 6.4 (2.7) 5.1 (3.1) 1.3 (0.4; 2.2)
Paraesthesia during the day (0–10)** 5.5 (2.9) 4.0 (3.4) 1.5 (0.5; 2.5)
Paraesthesia at night (0–10)** 5.2 (3.6) 4.5 (3.4) 0.7 (-0.4; 1.8)
Utility (EuroQol; 0–1)*** 0.85 (0.12) 0.81 (0.16) 0.04 (-0.004; 0.08)
  1. *Presented are the difference in success rate and the differences in the mean improvements from baseline (95% confidence interval); **Presented are the success rate and the mean (standard deviation) improvements from baseline; ***Utility is scored for one year.